American National Insurance’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
AIM
NAMA
American National Insurance's EXAS Position: Q1 2022 in Review
American National Insurance reduced its Exact Sciences (EXAS) stake by 19% in Q1 2022, selling an estimated $191K and leaving 11,200 shares worth $783K. The position accounts for 0.21% of the portfolio, ranked #136.
American National Insurance first reported a position in EXAS in Q1 2015 and has held it in 29 quarters since. The position peaked at $14.9M in Q2 2019. 559 funds tracked by Wall St. Rank hold EXAS as of Q1 2022.
- American National Insurance held 11,200 shares of Exact Sciences worth $783K as of Q1 2022.
- American National Insurance sold 2,615 Exact Sciences shares in Q1 2022, an estimated $191K.
- Exact Sciences made up 0.21% of American National Insurance's portfolio in Q1 2022, its #136 holding.
- American National Insurance first reported a position in Exact Sciences in Q1 2015 and has held it in 29 quarters since.
- American National Insurance's Exact Sciences position peaked at $14.9M in Q2 2019.
- 559 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2022.
Based on American National Insurance's 13F filing for Q1 2022, filed 13 May 2022.